Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy

被引：2

作者：

Brooks, Kristina M. ^{[1
]}

Scarsi, Kimberly K. ^{[2
]}

Mirochnick, Mark ^{[3
]}

机构：

[1] Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus,12850 East Montview Blvd,Mail, Aurora, CO 80045 USA

[2] Univ Nebraska Med Ctr, Nebraska Med Ctr 986145, Dept Pharm Practice & Sci, Room 3021, Omaha, NE 68198 USA

[3] Boston Univ, Sch Med, 801 Albany St,Room 2021, Boston, MA 02118 USA

来源：

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 2023年 / 50卷 / 01期

关键词：

HIV; Pharmacokinetics; Pregnant; Obstetric care; Antiretroviral therapy; Preexposure prophylaxis; POSTPARTUM WOMEN; TENOFOVIR ALAFENAMIDE; PHARMACOKINETICS; DARUNAVIR; STANDARD; IMPACT; RILPIVIRINE; COBICISTAT; NEVIRAPINE; LAMIVUDINE;

D O I：

10.1016/j.ogc.2022.10.013

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

An estimated 1.3 million births occurred worldwide in women with human immuno-deficiency virus (HIV) in 2020.1 Globally, HIV-related illnesses remain the leading cause of death among women of reproductive age, and approximately 6000 women acquire HIV every week. Collectively, these numbers demonstrate a need to reduce the morbidity and mortality associated with HIV, prevent new infections,

引用

页码：205 / 218

页数：14

共 50 条

[1] Enhanced and Timely Investigation of ARVs for Use in Pregnant Women
Abrams, Elaine J.
Mofenson, Lynne M.
Pozniak, Anton
Lockman, Shahin
Colbers, Angela
Belew, Yodit
Clayden, Polly
Mirochnick, Mark
Siberry, George K.
Ford, Nathan
Khoo, Saye
Renaud, Francoise
Vitoria, Marco
Venter, Willem D. F.
Doherty, Meg
Penazzato, Martina
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 86 (05) : 607 - 615
[2] [Anonymous], 2017, START FREE STAY FREE
[3] [Anonymous], Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
[4] Lopinavir protein binding in HIV-1-infected pregnant women
Aweeka, F. T.
Stek, A.
Best, B. M.
Hu, C.
Holland, D.
Hermes, A.
Burchett, S. K.
Read, J.
Mirochnick, M.
Capparelli, E. V.
[J]. HIV MEDICINE, 2010, 11 (04) : 232 - 238
[5] Pregnancy-Related Effects on Lamivudine Pharmacokinetics in a Population Study with 228 Women
Benaboud, Sihem
Treluyer, Jean Marc
Urien, Saik
Blanche, Stephane
Bouazza, Naim
Chappuy, Helene
Rey, Elisabeth
Pannier, Emmanuelle
Firtion, Ghislaine
Launay, Odile
Hirt, Deborah
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (02) : 776 - 782
[6] Pharmacokinetics of tenofovir during pregnancy and postpartum
Best, B. M.
Burchett, S.
Li, H.
Stek, A.
Hu, C.
Wang, J.
Hawkins, E.
Byroads, M.
Watts, D. H.
Smith, E.
Fletcher, C. V.
Capparelli, E. V.
Mirochnick, M.
[J]. HIV MEDICINE, 2015, 16 (08) : 502 - 511
[7] Impact of pregnancy on abacavir pharmacokinetics
Best, BM
Mirochnick, M
Capparelli, EV
Stek, A
Burchett, SK
Holland, DT
Read, JS
Smith, E
Hu, CC
Spector, SA
Connor, JD
[J]. AIDS, 2006, 20 (04) : 553 - 560
[8] Lopinavir Tablet Pharmacokinetics With an Increased Dose During Pregnancy
Best, Brookie M.
Stek, Alice M.
Mirochnick, Mark
Hu, Chengcheng
Li, Hong
Burchett, Sandra K.
Rossi, Steven S.
Smith, Elizabeth
Read, Jennifer S.
Capparelli, Edmund V.
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (04) : 381 - 388
[9] The Effect of Pregnancy on the Pharmacokinetics of Total and Unbound Dolutegravir and Its Main Metabolite in Women Living With Human Immunodeficiency Virus
Bollen, Pauline
Freriksen, Jolien
Konopnicki, Deborah
Weizsacker, Katharina
Tenorio, Carmen Hidalgo
Molto, Jose
Taylor, Graham
Alba-Alejandre, Irene
van Crevel, Reinout
Colbers, Angela
Burger, David
[J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (01) : 121 - 127
[10] Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint
Boyd, Sarita D.
Sampson, Mario R.
Viswanathan, Prabha
Struble, Kimberly A.
Arya, Vikram
Sherwat, Adam, I
[J]. AIDS, 2019, 33 (06) : 1089 - 1093

← 1 2 3 4 5 →